Salvia grossheimii
Salvia grossheimii · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Salvia grossheimii is a noteworthy botanical species currently being investigated for its diverse pharmacological potential. Research focuses primarily on the medicinal properties found within its aerial parts. The plant has demonstrated significant biological activities, most notably its antidiabetic and cytotoxic effects. Furthermore, its therapeutic applications are being explored in the context of managing diabetes and addressing challenges related to COVID-19. These findings suggest that this species could play a vital role in future drug development.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Salvia grossheimii, widely known by its common name Шалфей Гроссгейма, is a distinctive species within the Lamiaceae family. This plant is characterized by its unique structural features and its specific ecological niche. Cultivators and botanists often seek it out for its ornamental potential and its place in scientific study. Understanding its growth patterns is essential for anyone interested in preserving its natural beauty. As a member of the sage genus, it contributes to the rich biodiversity of its native habitat.
Sources: Catalogue of Life (COL)
Taxonomy
Salvia grossheimii is a distinctive member of the kingdom Plantae. Within this vast botanical realm, it belongs to the class Equisetopsida. It is further classified under the order Lamiales, showcasing its evolutionary connections. As a representative of the genus Salvia, it fits perfectly into its specialized biological lineage. Finally, this species is a proud member of the Lamiaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Salvia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Salvia grossheimii is a distinctive species primarily found across the Asia-Temperate regions. Its natural range extends through the rugged landscapes of the Caucasus and the Transcaucasus. Additionally, this plant can be discovered throughout the diverse terrain of Western Asia. Specifically, it maintains a notable presence within the country of Iran. These geographic connections highlight the plant's specific ecological niche within the temperate zones of the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Salvia grossheimii is a self-supporting herb that maintains its own structure within its natural habitat. This growth form allows the plant to stand firmly without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Salvia grossheimii is a perennial herb recognized for containing several highly bioactive constituents. Recent studies have highlighted its significant antidiabetic activity, particularly through the identification of new oleanane and ursane-type triterpenoids. Furthermore, the plant possesses cytotoxic properties that make it a subject of interest for pharmacological research. Using molecular docking analysis, researchers identified specific compounds like 2, 6, and 7 that show promise as potential inhibitors for human α-glucosidase. These findings suggest that the unique phytochemical profile of S. grossheimii could serve as a valuable foundation for future drug development.
Compounds
Conditions
Salvia grossheimii contains bioactive triterpenoids that demonstrate potential for treating COVID-19 and managing diabetes. Through in-silico molecular docking, specific compounds from the plant were identified as inhibitors of the SARS-CoV-2 main protease. Additionally, certain triterpenoids showed high binding affinities toward human α-glucosidase, suggesting antidiabetic properties. Specifically, compounds 6 and 7 emerged as strong candidates for anti-COVID-19 applications, while compounds 2 and 6 showed promise for treating antidiabetic conditions. These chemical relationships position the plant as a valuable source for future drug development targeting both viral and metabolic diseases.
Preparations
Salvia grossheimii is prepared as aerial parts for the purpose of phytochemical extraction. Researchers utilized these specific aerial parts of the plant to perform extractions using dichloromethane. Through this process, several undescribed oleanane and ursane-type triterpenoids were successfully isolated. The identification of these bioactive compounds relied on the chemical constituents derived from the plant's upper structures. Consequently, the use of the aerial parts enabled the discovery of potential candidates for anti-COVID-19 and antidiabetic drug development.